- July 23, 2020
-- According to a recent report the U.S. point of care diagnostic market size will cross $11 billion by 2024.
The dynamic changes in the healthcare industry and increasing focus on patient-centered services will propel the demand of point-of-care diagnostics in the US. The implementation of reforms and policies that enable professionals to provide cost-effective and high-quality care to patients is revolutionizing the POCT market
. POC testing
is emerging as an alternative diagnostic model especially for people residing in remote locations of the country. The increasing awareness about diseases and focus on early diagnosis and disease prevention is contributing to the development of the U.S. point-of-care diagnostics market. The growing popularity of homecare or self-monitoring of diseases, especially self-blood glucose monitoring is contributing to the growth of point-of-care diagnostics distribution
network. The advent of remote healthcare & patient monitoring, miniaturization of diagnostic devices, wearable medical devices, and growing usage of smartphones for healthcare applications are some of the key factors contributing to the revenues. The growing popularity of self-testing modules
and growth of the in-vitro diagnostics
industry will create lucrative opportunities for the leading vendors. The rise in the number of rapid-onset and life-threatening conditions such as sepsis
and acute cardiac infarction
and will boost demand for POC systems. The ability of POCT
s to deliver immediate results thus providing improved patient care will improve, deliver faster and accurate results. This system will also increase the penetration of EMR/HER
, remote patient monitoring
and telehealth. The increasing awareness about disease management and self-monitoring will drive market revenues.
The emergence of wearable medical devices
, lab-on-a-chip technology, and growing usage of smartphones is driving the demand for point-of-care devices
. The growing availability of rapid tests
for diagnosing infectious diseases like HIV, TB or malaria, that enable physicians and patients to visualize the results from a smartphone and take appropriate clinical decisions will transform the market over the next few years.
Read more: https://www.arizton.com/market-reports/us-point-of-care-diagnostics-market